JetBlue Airways Q1 Adj. Earnings Beat Estimates, Revenues Match Expectations

JetBlue Airways Corp. (JBLU) on Tuesday reported a 53.8 percent fall in profit for the first quarter from last year, as higher revenues were more than offset by an increase in operating expenses. However, adjusted earnings per share for the quarter beat analysts' expectations, while revenues matched their estimates.

The company's net income for the first quarter was $42 million or $0.14 per share, down from $90 million or $0.28 in the year-ago period.

Adjusted earnings for the quarter were $0.16 per share, compared to $0.26 per share in the same period last year.

Total operating revenue for the quarter rose 6.7 percent to $1.87 billion from $1.75 billion in the year-ago period.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.12 per share for the quarter on revenues of $1.87 billion. Analysts' estimates typically exclude special items.

"This quarter our financial performance was mainly impacted by the calendar placement of Easter and Passover holidays and, as disclosed in March, a softer revenue environment than initially expected," said Robin Hayes, JetBlue's Chief Executive Officer.

Looking ahead to the second quarter, JetBlue expects capacity to increase between 4.5 percent and 6.5 percent year over year. For the full year 2019, JetBlue expects capacity to increase between 4.5 percent and 6.5 percent.

Revenue per available seat mile or RASM growth is expected to range between 1.0 percent and 4.0 percent for the second quarter, compared to the same period in 2018.

The company's outlook includes a benefit of 2.25 points of impact related to the calendar placement shift of Easter and Passover between the first and second quarters of 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IntegraDose Compounding Services, LLC has recalled a total of eleven lots of antibiotic medication cefazolin in the form of injection for the potential lack of sterility assurance, the U.S. Food and Drug Administration or FDA said in a statement. The lack of sterility resulted from compounding in a newly installed biologic safety cabinet without completing dynamic smoke study testing. While reporting financial results for the fourth quarter on Thursday, professional services company Accenture Plc (ACN) initiated earnings and revenue growth outlook for the full-year 2022, above analysts' estimates and also provided revenue outlook for the first quarter. For fiscal 2022, the company... Impossible Foods Inc., a plant-based meat maker, is bringing its new plant-based pork product to the restaurants in U.S., Hong Kong and Singapore. Starting Thursday, Impossible pork will be available at Momofuku Ssäm Bar in Manhattan, New York City. It will serve Spicy Rice Cakes with Impossible Pork Ragu. Restaurants across the U.S. and Hong Kong can now order Impossible Pork for their menus.
Follow RTT